9999999997-18-005768.txt : 20180517 9999999997-18-005768.hdr.sgml : 20180517 20180517092853 ACCESSION NUMBER: 9999999997-18-005768 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180517 ACTION DATE: 20180517 RECEIVED DATE: 20180517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 18841883 BUSINESS ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-321-5554 MAIL ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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end